These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37987655)

  • 1. Eryptosis: a driver of anemia in chronic kidney disease.
    Bissinger R; Qadri SM; Artunc F
    Curr Opin Nephrol Hypertens; 2024 Mar; 33(2):220-225. PubMed ID: 37987655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Should Be Responsible for Eryptosis in Chronic Kidney Disease?
    Li D; Zheng X; Zhang Y; Li X; Chen X; Yin Y; Hu J; Li J; Guo M; Wang X
    Kidney Blood Press Res; 2022; 47(6):375-390. PubMed ID: 35114677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Eryptosis in the Pathogenesis of Renal Anemia: Insights From Basic Research and Mathematical Modeling.
    Dias GF; Grobe N; Rogg S; Jörg DJ; Pecoits-Filho R; Moreno-Amaral AN; Kotanko P
    Front Cell Dev Biol; 2020; 8():598148. PubMed ID: 33363152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremia and Inadequate Oxygen Supply Induce Eryptosis and Intracellular Hypoxia in Red Blood Cells.
    Dias GF; Tozoni SS; Bohnen G; Grobe N; Rodrigues SD; Meireles T; Nakao LS; Pecoits-Filho R; Kotanko P; Moreno-Amaral AN
    Cell Physiol Biochem; 2021 Jul; 55(4):449-459. PubMed ID: 34259420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockage of the Na-K-ATPase signaling-mediated oxidant amplification loop elongates red blood cell half-life and ameliorates uremic anemia induced by 5/6th PNx in C57BL/6 mice.
    Liu J; Chaudhry M; Bai F; Chuang J; Chaudhry H; Al-Astal AY; Nie Y; Sollars V; Sodhi K; Seligman P; Shapiro JI
    Am J Physiol Renal Physiol; 2022 Jun; 322(6):F655-F666. PubMed ID: 35435001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red Blood Cell Lifespan Shortening in Patients with Early-Stage Chronic Kidney Disease.
    Li JH; Luo JF; Jiang Y; Ma YJ; Ji YQ; Zhu GL; Zhou C; Chu HW; Zhang HD
    Kidney Blood Press Res; 2019; 44(5):1158-1165. PubMed ID: 31550724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of eryptosis in patients with chronic kidney disease.
    Gok MG; Paydas S; Boral B; Onan E; Kaya B
    Int Urol Nephrol; 2022 Nov; 54(11):2919-2928. PubMed ID: 35469112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Induction of Eryptosis by Uremic Toxins and Inflammation Mediators in Healthy Red Blood Cells.
    Virzì GM; Mattiotti M; Clementi A; Milan Manani S; Battaglia GG; Ronco C; Zanella M
    J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia.
    Bonan NB; Steiner TM; Kuntsevich V; Virzì GM; Azevedo M; Nakao LS; Barreto FC; Ronco C; Thijssen S; Kotanko P; Pecoits-Filho R; Moreno-Amaral AN
    Blood Purif; 2016; 41(4):317-23. PubMed ID: 26848873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body iron transport and metabolism: Mechanistic, multi-scale model to improve treatment of anemia in chronic kidney disease.
    Sarkar J; Potdar AA; Saidel GM
    PLoS Comput Biol; 2018 Apr; 14(4):e1006060. PubMed ID: 29659573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eryptosis - the Neglected Cause of Anemia in End Stage Renal Disease.
    Lang F; Bissinger R; Abed M; Artunc F
    Kidney Blood Press Res; 2017; 42(4):749-760. PubMed ID: 29151105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremia and Hypoxia Independently Induce Eryptosis and Erythrocyte Redox Imbalance.
    Tozoni SS; Dias GF; Bohnen G; Grobe N; Pecoits-Filho R; Kotanko P; Moreno-Amaral AN
    Cell Physiol Biochem; 2019; 53():794-804. PubMed ID: 31661199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eryptosis in Patients with Chronic Kidney Disease: A Possible Relationship with Oxidative Stress and Inflammatory Markers.
    Clementi A; Virzì GM; Milan Manani S; Battaglia GG; Ronco C; Zanella M
    J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoxyl Sulfate, a Uremic Toxin, Stimulates Reactive Oxygen Species Production and Erythrocyte Cell Death Supposedly by an Organic Anion Transporter 2 (OAT2) and NADPH Oxidase Activity-Dependent Pathways.
    Dias GF; Bonan NB; Steiner TM; Tozoni SS; Rodrigues S; Nakao LS; Kuntsevich V; Pecoits Filho R; Kotanko P; Moreno-Amaral AN
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29976888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress, eryptosis and anemia: a pivotal mechanistic nexus in systemic diseases.
    Bissinger R; Bhuyan AAM; Qadri SM; Lang F
    FEBS J; 2019 Mar; 286(5):826-854. PubMed ID: 30028073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathormone enhances eryptosis in patients with end stage renal disease treated by hemodialysis.
    Hefny A; Fikry AA; Zahran MH; Shendi AM
    Hemodial Int; 2022 Apr; 26(2):234-242. PubMed ID: 34918440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Eryptotic Activity of Food-Derived Phytochemicals and Natural Compounds.
    Restivo I; Attanzio A; Tesoriere L; Allegra M; Garcia-Llatas G; Cilla A
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicidal erythrocyte death in end-stage renal disease.
    Abed M; Artunc F; Alzoubi K; Honisch S; Baumann D; Föller M; Lang F
    J Mol Med (Berl); 2014 Aug; 92(8):871-9. PubMed ID: 24743961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced eryptosis contributes to anemia in lung cancer patients.
    Bissinger R; Schumacher C; Qadri SM; Honisch S; Malik A; Götz F; Kopp HG; Lang F
    Oncotarget; 2016 Mar; 7(12):14002-14. PubMed ID: 26872376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism.
    Bissinger R; Nemkov T; D'Alessandro A; Grau M; Dietz T; Bohnert BN; Essigke D; Wörn M; Schaefer L; Xiao M; Beirne JM; Kalo MZ; Schork A; Bakchoul T; Omage K; Kong L; Gonzalez-Menendez I; Quintanilla-Martinez L; Fehrenbacher B; Schaller M; Dhariwal A; Birkenfeld AL; Grahammer F; Qadri SM; Artunc F
    Kidney Int; 2021 Dec; 100(6):1227-1239. PubMed ID: 34537228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.